Treatment of childhood tuberculosis: Caregivers’ practices and perceptions in Cape Town, South Africa

Paediatrics and International Child Health

Volumn 35, Issue 1, 2015, Pages 24-28

  Bélard, Sabine ^a,b,c   Isaacs, Washiefa ^a   Black, Faye ^a   Bateman, Lindy ^a   Madolo, Lucia ^a   Munro, Jacinta ^a   Workman, Lesley ^a   Grobusch, Martin P ^b,c   Zar, Heather J ^a,b  

^a RED CROSS WAR MEMORIAL CHILDREN S HOSPITAL   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Caregiver practice; Childhood tuberculosis; Perception; Treatment

Indexed keywords

TUBERCULOSTATIC AGENT;

ARTICLE; ATTITUDE TO HEALTH; CAREGIVER; CHILDHOOD DISEASE; DRUG RESISTANT TUBERCULOSIS; EXTRAPULMONARY TUBERCULOSIS; FEMALE; FOLLOW UP; HEALTH CARE PRACTICE; HEALTH SURVEY; HUMAN; INTERVIEW; MALE; MEDICATION THERAPY MANAGEMENT; PRACTICE GUIDELINE; PREVALENCE; PROSPECTIVE STUDY; QUESTIONNAIRE; SOUTH AFRICA; TUBERCULOSIS; ADOLESCENT; CHILD; INFANT; NEWBORN; PRESCHOOL CHILD; PSYCHOLOGY;

ADOLESCENT; ANTITUBERCULAR AGENTS; CAREGIVERS; CHILD; CHILD, PRESCHOOL; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INFANT; INFANT, NEWBORN; INTERVIEWS AS TOPIC; MALE; PROSPECTIVE STUDIES; QUESTIONNAIRES; SOUTH AFRICA; TUBERCULOSIS;

EID: 84920019744     PISSN: 20469047     EISSN: 20469055     Source Type: Journal    
DOI: 10.1179/2046905514Y.0000000133     Document Type: Article

References (16)

1. World Health Organization. Roadmap for childhood tuberculosis: Towards zero deaths. Geneva: WHO, 2013. Available from: http://www.theunion.org/images/stories/news/ChildhoodTBRoadmap_Final_1October2013.pdf
2. Marais BJ, Hesseling AC, Gie RP, Schaaf HS, Beyers N. The burden of childhood tuberculosis and the accuracy of community-based surveillance data. Int J Tuberc Lung Dis. 2006;10:259–63.
3. Zar HJ, Pai M. Childhood tuberculosis – a new era. Paediatr Respir Rev. 2011;12:1–2.
4. Craig SR, Adams LV, Spielberg SP, Campbell B. Pediatric therapeutics and medicine administration in resource-poor settings: A review of barriers and an agenda for interdisciplinary approaches to improving outcomes. Soc Sci Med. 2009;69:1681–90.
5. Zar HJ, Workman L, Isaacs W, Munro J, Black F, Eley B, et al. Rapid molecular diagnosis of pulmonary tuberculosis in children using nasopharyngeal specimens. Clin Infect Dis. 2012;55:1088–95.
6. Department of Health, South Africa. National Tuberculosis Management Guidelines, 2009.
7. Lin MY, Lin SJ, Chan LC, Lu YC. Impact of food and antacids on the pharmacokinetics of antituberculosis drugs: Systematic review and meta-analysis. Int J Tuberc Lung Dis. 2010;14:806–18.
8. Kiser JJ, Zhu R, D’Argenio DZ, Cotton MF, Bobat R, McSherry GD, et al. Isoniazid pharmacokinetics, pharmacodynamics, and dosing in South African infants. Ther Drug Monit. 2012;34:446–51.
9. Thee S, Seddon JA, Donald PR, Seifart HI, Werely CJ, Hesseling AC, et al. Pharmacokinetics of isoniazid, rifampin, and pyrazinamide in children younger than two years of age with tuberculosis: evidence for implementation of revised World Health Organization recommendations. Antimicrob Agents Chemother. 2011;55:5560–7.
10. Pasipanodya JG, McIlleron H, Burger A, Wash PA, Smith P, Gumbo T. Serum drug concentrations predictive of pulmonary tuberculosis outcomes. J Infect Dis. 2013;208: 1464–73.
11. Ramachandran G, Hemanth Kumar AK, Bhavani PK, Poorana Gangadevi N, Sekar L, Vijayasekaran D, et al. Age, nutritional status and INH acetylator status affect pharmacokinetics of anti-tuberculosis drugs in children. Int J Tuberc Lung Dis. 2013;17:800–6.
12. Donald PR, Ahmed A, Burman WJ, Cotton MF, Graham SM, Mendel C, et al. Requirements for the clinical evaluation of new anti-tuberculosis agents in children. Int J Tuberc Lung Dis. 2013;17:794–9.
13. Best BM, Capparelli EV, Diep H, Rossi SS, Farrell MJ, Williams E, et al. Pharmacokinetics of lopinavir/ritonavir crushed versus whole tablets in children. J Acquir Immun Defic Syndr. 2011;58:385–91.
14. Notterman DA, Nardi M, Saslow JG. Effect of dose formulation on isoniazid absorption in two young children. Pediatrics. 1986;77:850–2.
15. Kurth F, Belard S, Adegnika AA, Gaye O, Kremsner PG, Ramharter M. Do paediatric drug formulations of artemisinin combination therapies improve the treatment of children with malaria? A systematic review and meta-analysis. Lancet Infect Dis. 2010;10:125–32.
16. Waning B, Diedrichsen E, Jambert E, Barnighausen T, Li Y, Pouw M, et al. The global pediatric antiretroviral market: analyses of product availability and utilization reveal challenges for development of pediatric formulations and HIV/AIDS treatment in children. BMC Pediatr. 2010;10: 74.